CN109678862A - 一种多取代二苯乙烯基吲哚衍生物的制备方法 - Google Patents
一种多取代二苯乙烯基吲哚衍生物的制备方法 Download PDFInfo
- Publication number
- CN109678862A CN109678862A CN201910171599.8A CN201910171599A CN109678862A CN 109678862 A CN109678862 A CN 109678862A CN 201910171599 A CN201910171599 A CN 201910171599A CN 109678862 A CN109678862 A CN 109678862A
- Authority
- CN
- China
- Prior art keywords
- diphenylethyllene
- indole derivatives
- indole
- polysubstituted
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940054051 antipsychotic indole derivative Drugs 0.000 title claims abstract description 15
- 150000002475 indoles Chemical class 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- -1 4- isopropyl methyl phenyl Chemical group 0.000 claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 239000012043 crude product Substances 0.000 claims abstract description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract description 6
- 125000003963 dichloro group Chemical group Cl* 0.000 claims abstract description 6
- 235000017281 sodium acetate Nutrition 0.000 claims abstract description 6
- 239000001632 sodium acetate Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- CZCXETFSJAOEHW-UHFFFAOYSA-N C(=O)N.CON1C=CC2=CC=CC=C12 Chemical compound C(=O)N.CON1C=CC2=CC=CC=C12 CZCXETFSJAOEHW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims abstract description 5
- 150000001608 tolans Chemical class 0.000 claims abstract description 5
- 230000035484 reaction time Effects 0.000 claims abstract description 4
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 238000001311 chemical methods and process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 238000010189 synthetic method Methods 0.000 abstract description 4
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 26
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- LSSICPJTIPBTDD-UHFFFAOYSA-N 2-ethenyl-1h-indole Chemical class C1=CC=C2NC(C=C)=CC2=C1 LSSICPJTIPBTDD-UHFFFAOYSA-N 0.000 description 7
- 229910000144 sodium(I) superoxide Inorganic materials 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940120124 dichloroacetate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了属于有机合成技术领域的一种新型多取代二苯乙烯基吲哚衍生物的制备方法。所述方法为:向反应器中,加入取代N‑甲氧基吲哚甲酰胺,二苯乙炔,二氯双(4‑甲基异丙基苯基)钌(Ⅱ),乙酸钠。在溶剂中搅拌反应结束后,使用旋转蒸发仪浓缩滤液得到粗产物,粗产物用硅胶柱层析分离得到目标化合物。本发明提供的多取代二苯乙烯基吲哚衍生物的合成方法具有科学合理,合成方法简单,目标化合物收率高,产品易于纯化,反应时间较短,反应条件为室温水相,环境友好度高等特点。其反应方程式如下:
Description
技术领域
本发明属于有机合成技术领域,具体涉及一种二苯乙烯基吲哚衍生物的制备方法。
背景技术
含氮杂环广泛存在于天然产物以及具有生物和医药活性的分子中。在这些杂环化合物中,乙烯基吲哚类化合物在药物设计和合成中起到了不可或缺的作用。例如,抗肿瘤药、抗感染药和消炎药等药物中均包含乙烯基吲哚的分子片段。((a)WO2008122620A1.(b)WO2014033597A1.)
鉴于乙烯基吲哚衍生物的广泛的生物活性和应用价值,发展一种实用有效地合成乙烯基吲哚衍生物的新方法具有重要意义。
合成乙烯基吲哚衍生物的方法有:
1)2006年,Nakao和Hiyama课题组报道了镍催化下N-甲基或酯基吲哚类物质和炔烃合成乙烯基吲哚衍生物。(J.Am.Chem.Soc.2006,128,8146.)
2)2012年,Yoshikai课题组报道了以N-嘧啶基吲哚类物质和炔烃在钴催化下合成乙烯基吲哚衍生物。(Angew.Chem.Int.Ed.2012,51,4698.)
制备乙烯基吲哚衍生物的上述方法中的明显缺点:反应时间较长、使用了甲苯或四氢呋喃等具有毒性的溶剂。
发明内容
本发明提供了一种在室温、水相条件下制备多取代二苯乙烯基吲哚衍生物的方法。
一种多取代二苯乙烯基吲哚衍生物的制备方法,所述二苯乙烯基吲哚衍生物具有式Ⅰ所示的结构:
R取代基团选自氯、溴、甲氧基、甲基;其特征在于,向反应器中,加入取代N-甲氧基吲哚甲酰胺,二苯乙炔,二氯双(4-甲基异丙基苯基)钌(Ⅱ),乙酸钠。在溶剂中搅拌反应完毕后,使用旋转蒸发仪浓缩得到粗产物,粗产物使用硅胶柱层析分离得到目标产物,其化学过程见反应式Ⅱ:
所述的取代N-甲氧基吲哚甲酰胺,二苯乙炔,二氯双(4-甲基异丙基苯基)钌(Ⅱ),乙酸钠的摩尔比值为1:1:0.05:2。所述溶剂为水:二氯甲烷=9:1,反应温度为室温,反应时间为3h。
本发明的有益效果为:本发明提供的多取代二苯乙烯基吲哚衍生物的合成方法科学合理,提供了一种合成多取代二苯乙烯基吲哚衍生物的新途径,通过本方法得到了具有多种取代基的二苯乙烯基吲哚衍生物,其特点为:合成方法简单,目标化合物收率高,产品易于纯化,反应时间较短,反应条件为室温水相,环境友好度高。
附图说明
图1为实施例1制备的化合物3aa的NMR图谱;
图2为实施例4制备的化合物3da的NMR图谱;
图3为实施例8制备的化合物3ha的NMR图谱。
具体实施方式
下面结合附图和具体的实施例对本发明进一步详细的说明:
下述实施例中所述试验方法,如无特殊说明,均为常规方法;所述试剂和材料,如无特殊说明,均可从商业途径获得。
实施例1
二苯乙烯基吲哚衍生物3aa的制备
向15ml厚壁耐压管中加入N-甲氧基吲哚甲酰胺1a(0.1mmol,19.0mg)、2a(0.1mmol,17.8mg)、二氯双(4-甲基异丙基苯基)钌(Ⅱ)(0.005mmol,3.1mg)和乙酸钠(0.2mmol,27.2mg)加入水:二氯甲烷(1.0mL,9:1),在室温下搅拌,反应3小时。反应完毕后,使用旋转蒸发仪除去溶剂得到粗产物,粗产物经柱层析分离(200-300目硅胶)(石油醚/乙酸乙酯=4/1),使用旋转蒸发仪除去溶剂,得到目标产物无取代二苯乙烯基吲哚衍生物3aa,其收率为99%。
谱图解析数据3aa:
1H NMR(400MHz,DMSO-d6)δ11.53(s,1H),10.44(s,1H),7.51(d,J=7.8Hz,1H),7.32(d,J=8.1Hz,1H),7.24(dd,J=5.0,1.7Hz,3H),7.20–7.13(m,3H),7.09–7.02(m,5H),7.00–6.94(m,1H),6.68(d,J=1.5Hz,1H),3.42(s,3H).13C NMR(101MHz,DMSO-d6)δ166.5,139.0,137.6,137.4,137.3,135.3,134.6,131.0,129.6,128.5,128.3,128.0,127.7,122.3,120.6,119.7,112.1,104.4,62.8.HRMS(ESI)m/z calcd for C24H20N2NaO2 +[M+Na]+391.1422,found 391.1418.
实施例2
用1b代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3ba:
1H NMR(400MHz,DMSO-d6)δ11.57(s,1H),10.68(s,1H),7.73(d,J=1.7Hz,1H),7.29(d,J=8.6Hz,1H),7.24(dd,J=5.0,1.6Hz,3H),7.18(d,J=1.9Hz,2H),7.16(d,J=3.0Hz,2H),7.09–7.02(m,4H),6.68(d,J=1.6Hz,1H),3.42(s,3H).13C NMR(101MHz,DMSO-d6)δ166.2,138.9,138.8,137.4,136.0,135.5,134.8,130.9,129.8,129.58,128.6,128.6,128.4,127.8,124.7,122.7,114.1,112.2,103.8,62.9.HRMS(ESI)m/z calcd forC24H19BrN2NaO2 +[M+Na]+469.0528,found 469.0528.
实施例3
用1c代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3ca:
1H NMR(400MHz,DMSO-d6)δ11.56(s,1H),10.67(s,1H),7.59(d,J=2.0Hz,1H),7.33(d,J=8.6Hz,1H),7.25(dd,J=5.0,1.7Hz,3H),7.19(s,1H),7.16(d,J=2.6Hz,2H),7.05(ddt,J=7.4,3.3,1.7Hz,5H),6.68(d,J=1.5Hz,1H),3.42(s,3H).13C NMR(101MHz,DMSO-d6)δ171.0,143.8,143.5,142.2,140.5,140.2,139.5,135.7,134.3,133.81,133.4,133.3,133.2,132.6,129.0,127.0,124.4,118.4,108.7,67.6.HRMS(ESI)m/z calcd forC24H19ClN2NaO2 ++[M+Na]+425.1033,found 425.1028.
实施例4
用1d代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3da:
1H NMR(400MHz,DMSO-d6)δ11.52(s,1H),10.25(s,1H),7.25–7.22(m,3H),7.21(s,1H),7.18–7.09(m,3H),7.08–7.02(m,4H),7.01(d,J=2.4Hz,1H),6.71(dd,J=8.8,2.4Hz,1H),6.60(d,J=1.7Hz,1H),3.74(s,3H),3.45(s,3H).13C NMR(101MHz,DMSO-d6)δ166.5,154.0,139.1,137.8,137.7,135.3,134.2,132.6,131.0,129.6,128.5,128.3,128.3,127.6,112.9,104.3,101.8,62.9,55.7.HRMS(ESI)m/z calcd for C25H22N2NaO3 +[M+Na]+421.1528,found 421.1528.
实施例5
用1e代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3ea:
1H NMR(400MHz,DMSO-d6)δ11.51(s,1H),10.27(s,1H),7.28(s,1H),7.23(dd,J=5.1,1.7Hz,3H),7.20(s,1H),7.18–7.12(m,3H),7.05(dt,J=8.2,4.2Hz,4H),6.89(dd,J=8.3,1.4Hz,1H),6.58(d,J=1.5Hz,1H),3.42(s,3H),2.34(s,3H).13C NMR(101MHz,DMSO-d6)δ166.5,139.1,137.7,137.4,135.8,135.4,134.3,131.0,129.6,128.5,128.3,128.2,128.1,127.6,124.0,120.0,111.8,104.0,62.8,21.7.HRMS(ESI)m/z calcd forC25H22N2NaO2 +[M+Na]+405.1579,found 405.1575.
实施例6
用1f代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3fa:
1H NMR(400MHz,DMSO-d6)δ11.53(s,1H),10.42(s,1H),7.24(dd,J=5.0,1.8Hz,3H),7.18–7.12(m,3H),7.08–7.02(m,4H),7.01–6.95(m,1H),6.93(d,J=8.1Hz,1H),6.72(d,J=1.7Hz,1H),6.47(d,J=7.5Hz,1H),3.85(s,3H),3.45(s,3H).13C NMR(101MHz,DMSO-d6)δ166.5,153.2,139.1,138.6,137.7,135.8,135.2,134.1,131.0,129.6,128.5,128.5,128.3,127.6,123.2,118.7,105.5,101.9,99.5,62.8,55.4.HRMS(ESI)m/z calcd forC25H22N2NaO3 +[M+Na]+421.1528,found 421.1526.
实施例7
用1g代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3ga:
1H NMR(400MHz,DMSO-d6)δ11.59(s,1H),10.92–10.82(m,1H),7.34(d,J=8.1Hz,1H),7.25(dd,J=5.0,1.9Hz,3H),7.21(s,1H),7.20–7.16(m,3H),7.09–7.03(m,4H),7.03–6.98(m,1H),6.73(d,J=1.6Hz,1H),3.46(s,3H).13C NMR(101MHz,DMSO-d6)δ166.2,138.6,138.3,137.6,137.4,135.8,134.6,129.5,128.7,128.6,128.5,128.4,127.9,123.4,122.3,113.6,111.72,103.9,62.7.HRMS(ESI)m/z calcd for C24H19BrN2NaO2 +[M+Na]+469.0528,found 469.0526.
实施例8
用1h代替实例1中的1a,其他条件同实例1,实验结果见表1。
谱图解析数据3ha:
1H NMR(400MHz,DMSO-d6)δ11.58(s,1H),10.60(s,1H),7.53–7.48(m,2H),7.26(dd,J=5.0,1.7Hz,3H),7.20(s,1H),7.17(d,J=6.7Hz,2H),7.11(dd,J=8.5,1.7Hz,1H),7.09–7.03(m,4H),6.73–6.69(m,1H),3.42(s,3H).13C NMR(101MHz,DMSO-d6)δ166.3,138.7,138.4,138.12,137.4,135.3,134.8,131.0,129.6,128.7,128.6,128.5,127.8,127.0,122.6,122.4,114.9,114.6,104.5,62.8.HRMS(ESI)m/z calcd for C24H19BrN2NaO2 +[M+Na]+469.0528,found 469.0519.
表1
Claims (3)
1.一种多取代二苯乙烯基吲哚衍生物的制备方法,所述二苯乙烯基吲哚衍生物具有式Ⅰ所示的结构:
R取代基团选自氯、溴、甲氧基、甲基;其特征在于,向反应器中,加入取代N-甲氧基吲哚甲酰胺,二苯乙炔,二氯双(4-甲基异丙基苯基)钌(Ⅱ),乙酸钠。在溶剂中搅拌反应完毕后,使用旋转蒸发仪浓缩得到粗产物,粗产物使用硅胶柱层析分离得到目标产物,其化学过程见反应式Ⅱ:
2.根据权利要求1所述的制备方法,所述的取代N-甲氧基吲哚甲酰胺,二苯乙炔,二氯双(4-甲基异丙基苯基)钌(Ⅱ),乙酸钠的摩尔比值为1:1:0.05:2。
3.按照权利要求1所述的制备方法,其特征在于:所述溶剂为水:二氯甲烷=9:1,反应温度为室温,反应时间为3h。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810894335.0A CN109053736A (zh) | 2018-08-08 | 2018-08-08 | 一种吡咯并[1,2-α]吲哚-3-醇衍生物的制备方法 |
CN2018108943350 | 2018-08-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109678862A true CN109678862A (zh) | 2019-04-26 |
CN109678862B CN109678862B (zh) | 2021-04-27 |
Family
ID=64678097
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810894335.0A Withdrawn CN109053736A (zh) | 2018-08-08 | 2018-08-08 | 一种吡咯并[1,2-α]吲哚-3-醇衍生物的制备方法 |
CN201910171599.8A Active CN109678862B (zh) | 2018-08-08 | 2019-03-07 | 一种多取代二苯乙烯基吲哚衍生物的制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810894335.0A Withdrawn CN109053736A (zh) | 2018-08-08 | 2018-08-08 | 一种吡咯并[1,2-α]吲哚-3-醇衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN109053736A (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113666935A (zh) * | 2021-09-06 | 2021-11-19 | 上海交通大学 | 一种手性吲哚并吡咯类生物碱及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742007A (zh) * | 2003-01-22 | 2006-03-01 | 伊莱利利公司 | 甾族激素核受体的吲哚衍生物调控剂 |
US20100124037A1 (en) * | 2008-11-18 | 2010-05-20 | Samsung Electronics Co., Ltd. | Thermosetting composition and printed circuit board using the same |
CN105001662A (zh) * | 2015-06-08 | 2015-10-28 | 青岛科技大学 | 一类硼酸基五甲川菁荧光染料的制备方法及应用 |
CN105669698A (zh) * | 2016-02-25 | 2016-06-15 | 青岛科技大学 | 一种多取代噻喃并吲哚衍生物的制备方法 |
-
2018
- 2018-08-08 CN CN201810894335.0A patent/CN109053736A/zh not_active Withdrawn
-
2019
- 2019-03-07 CN CN201910171599.8A patent/CN109678862B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742007A (zh) * | 2003-01-22 | 2006-03-01 | 伊莱利利公司 | 甾族激素核受体的吲哚衍生物调控剂 |
US20100124037A1 (en) * | 2008-11-18 | 2010-05-20 | Samsung Electronics Co., Ltd. | Thermosetting composition and printed circuit board using the same |
CN105001662A (zh) * | 2015-06-08 | 2015-10-28 | 青岛科技大学 | 一类硼酸基五甲川菁荧光染料的制备方法及应用 |
CN105669698A (zh) * | 2016-02-25 | 2016-06-15 | 青岛科技大学 | 一种多取代噻喃并吲哚衍生物的制备方法 |
Non-Patent Citations (2)
Title |
---|
YANAN XIE等,: ""Ruthenium(II)-Catalyzed Redox-Neutral [3+2] Annulation of Indoles with Internal Alkynes via C−H Bond Activation: Accessing a Pyrroloindolone Scaffold"", 《J. ORG. CHEM.》 * |
王婷婷: ""Stereoselective Synthesis of Tetrasubstituted Alkenes via a Cp*CoIII-Catalyzed C-H Alkenylation/Directing Group Migration Sequence"及其Supporting Information", 《ANGEW. CHEM. INT. ED..》 * |
Also Published As
Publication number | Publication date |
---|---|
CN109678862B (zh) | 2021-04-27 |
CN109053736A (zh) | 2018-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108069934B (zh) | 钌催化联苯型芳酮与二苯乙炔反应制备多芳取代萘衍生物的方法 | |
CN110105305B (zh) | 过渡金属催化的c-h活化/环合合成1,2-苯并噻嗪衍生物的绿色合成方法 | |
CN108752299B (zh) | 一种3-苯并呋喃酮类化合物的制备方法 | |
CN102432485B (zh) | 一种α,β-二氨基酸衍生物及其合成方法和应用 | |
CN109678862A (zh) | 一种多取代二苯乙烯基吲哚衍生物的制备方法 | |
CN109879792B (zh) | 一种多取代异吲哚类化合物及其制备方法 | |
CN108727385A (zh) | 一种多取代二氢嘧啶并吲哚酮衍生物的制备方法 | |
CN108191736B (zh) | 一种2,3-二取代吲哚类衍生物及其制备方法 | |
CN111362795B (zh) | 一类取代丁酸酯类衍生物的制备方法 | |
CN109734667B (zh) | 一种多取代咪唑化合物及其合成方法和应用 | |
CN111087401B (zh) | 一种在2-芳基喹唑啉-4(3h)-酮类化合物上建立螺环的新方法 | |
CN112209947A (zh) | 一种手性吲哚并噁嗪酮化合物及其合成方法 | |
CN108276420B (zh) | 一种8,13-二氢苯并[5,6]色烯并[2,3-b]吲哚类化合物及其合成方法 | |
CN106588984B (zh) | 一种6-磷酰基取代菲啶类衍生物的制备方法 | |
CN107445835B (zh) | 一种1,2-二氢环丁烯并[a]萘衍生物及其前体的合成方法 | |
Enders et al. | A practical approach towards the asymmetric synthesis of α, γ-substituted γ-sultones | |
CN115215783B (zh) | 炔丙基取代的手性3-氨基-3,3-双取代氧化吲哚类化合物、其合成方法及应用 | |
CN111056915A (zh) | 一种1,2-二烷基-1,2-二芳基乙炔基环丁烷的合成方法 | |
CN112745275B (zh) | 1,3,4-恶二唑杂环化合物的合成方法 | |
CN110256349B (zh) | 多取代吡唑及其制备方法 | |
CN106810482B (zh) | 一种3-苯硒基-1-丙酮衍生物及其合成方法 | |
CN108129479B (zh) | 一种5,6-二氢苯并[f]吲哚并[2,3-b]喹啉类化合物及其合成方法 | |
CN116354806B (zh) | 一种含全碳季碳环戊烯酮衍生物的膦催化制备方法 | |
CN110204456B (zh) | 多取代萘衍生物及其合成方法 | |
CN109705052B (zh) | 一种制备1,4-二氢噁嗪的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240104 Address after: 256600 south side of xinyongxin Road, Binbei office, Bincheng District, Binzhou City, Shandong Province Patentee after: Shoujian Technology Co.,Ltd. Address before: No. 53, Zhengzhou Road, North District, Qingdao, Shandong Patentee before: QINGDAO University OF SCIENCE AND TECHNOLOGY |
|
TR01 | Transfer of patent right |